RTA-3

Price range: $110.00 through $2,000.00

Save More by Buying Bio Bulk Box

*Products are shipped within 24 hours to 2 weeks depending on availablity.*

Description

RTA-3 (Research Use Only)

Description:

RTA-3 is a cutting-edge investigational peptide designed for research use in metabolic and weight regulation studies. It functions as a triple agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-receptor activity makes RTA-3 a next-generation peptide of interest for researchers exploring mechanisms related to energy balance, glucose metabolism, fat oxidation, and body composition.

Preclinical and early clinical research has indicated that RA-3 may significantly influence insulin sensitivity, satiety, and energy expenditure, offering a unique platform for studying metabolic and obesity-related pathways.

Research Applications:

  • Studies on glucose and insulin signaling pathways
  • Investigations of metabolic regulation and body composition
  • Evaluation of multi-receptor peptide mechanisms
  • Research on glucagon and incretin modulation

Storage:

Store lyophilized RTA-3 in a cool, dry place at temperatures below -20°C. Once reconstituted with bacteriostatic water (BAC water), store under refrigeration (2–8°C) and use within 20 days for optimal stability.

Disclaimer:

  • For Research Use Only.
  • Not for human consumption.
  • Not approved for medical, veterinary, or household use.
  • This product is intended solely for in vitro laboratory research purposes, including reagent development, biochemical assay, and molecular investigation.
  • The information provided on this page is for educational and informational purposes only and does not constitute medical advice, guidance, or endorsement of any therapeutic use.
  • Researchers should handle all peptides with proper laboratory safety procedures and in compliance with institutional and local regulations.

Additional information

Specification

, , , , , , , , , , , , ,